274 Early clinical trials have reported telmisartan improved NAFLD and fibrosis scores, as well as evidence of steatosis and inflammation on liver biopsy, in NASH patients
Neuroinflammation, Alzheimers, Parkinsons, and Cognition Neuroinflammation, Alzheimers, Parkinsons, and Cognition Emerging research is also showing promise for GLP-1 drugs in treatment of neurodegenerative diseases
Preclinical studies have consistently shown that targeting ferroptosis with drugs such as iron chelators, lipid peroxidation inhibitors or NRF2 activators can produce significant neuroprotective effects
Statistical Analysis Data were analyzed using Pulsefit (HEKA Elektronik, Lambrecht/Pfalz, Germany), Igor 4.0 (WaveMetrics, Lake Oswego, USA), and SigmaPlot 12.0 (Systat Software, Inc., San Jose, USA)